Regencell Bioscience Holdings Limited Stock
Equities
RGC
KYG7487R1002
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.7 USD | -6.19% | -6.19% | -55.24% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 300M |
---|---|---|---|---|---|
Net income 2022 | -7M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 15.65M | Net cash position 2023 | 11.1M | EV / Sales 2023 | - |
P/E ratio 2022 |
-59.5
x | P/E ratio 2023 |
-51.1
x | Employees | 12 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 11.24% |
1 day | -6.19% | ||
1 week | -6.19% | ||
1 month | -27.58% | ||
3 months | -28.13% | ||
6 months | -56.64% | ||
Current year | -55.24% |
Managers | Title | Age | Since |
---|---|---|---|
Wai Hong Chung
COO | Chief Operating Officer | 46 | - |
Yi-Chung Chao
CTO | Chief Tech/Sci/R&D Officer | 59 | 20-09-30 |
Yat-Pui Au
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wing Yan Lo
BRD | Director/Board Member | 63 | 21-12-12 |
Yi-Chung Chao
CTO | Chief Tech/Sci/R&D Officer | 59 | 20-09-30 |
- | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-29 | 4.7 | -6.19% | 1,114 |
Delayed Quote Nasdaq, May 29, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-55.24% | 61.16M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.40% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- RGC Stock